{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:57:54Z","timestamp":1793681874727,"version":"4.5.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,7,10]],"date-time":"2008-07-10T00:00:00Z","timestamp":1215648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s11136-008-9365-y","type":"journal-article","created":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T09:57:30Z","timestamp":1215597450000},"page":"831-843","source":"Crossref","is-referenced-by-count":58,"title":["Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials"],"prefix":"10.1007","volume":"17","author":[{"given":"Franck","family":"Bonnetain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Doffoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Luc","family":"Raoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadil","family":"Masskouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Barbare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bedenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,10]]},"reference":[{"key":"9365_CR1","doi-asserted-by":"crossref","unstructured":"Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001). Estimating the world cancer burden. GLOBOCAN 2000. International Journal of Cancer, 94, 153\u2013156. doi: 10.1002\/ijc.1440.","DOI":"10.1002\/ijc.1440"},{"key":"9365_CR2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","volume":"139","author":"H. B. El Serag","year":"2003","unstructured":"El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003). The continuing increase in the incidence of hepatocellular carcinoma in the United States - An update. Annals of Internal Medicine, 139, 817\u2013823.","journal-title":"Annals of Internal Medicine"},{"key":"9365_CR3","first-page":"3","volume":"51","author":"L. Remontet","year":"2003","unstructured":"Remontet, L., Esteve, J., Bouvier, A. M., et\u00a0al. (2003). Cancer incidence and mortality in France over the period 1978\u20132000. Revue d\u2019Epidemiologie et de Sante Publique, 51, 3\u201330.","journal-title":"Revue d\u2019Epidemiologie et de Sante Publique"},{"key":"9365_CR4","doi-asserted-by":"crossref","unstructured":"Garcia, S. F., Cella, D., Clauser, S., et\u00a0al. (2007). Enhancing patient-reported outcomes assessment in cancer clinical trials: The PROMIS initiative. Journal of Clinical Oncology, 25, 5106\u20135112. doi: 10.1200\/JCO.2007.12.2341.","DOI":"10.1200\/JCO.2007.12.2341"},{"key":"9365_CR5","first-page":"1","volume":"346","author":"S. F. Garcia","year":"1995","unstructured":"Garcia, S. F., Cella, D., Clauser, S., et\u00a0al. (1995). Editorial. Quality of life and clinical trials. Lancet, 346, 1\u20132.","journal-title":"Lancet"},{"key":"9365_CR6","first-page":"7","volume":"20","author":"J. Beitz","year":"1996","unstructured":"Beitz, J., Gnecco, C., & Justice, R. (1996). Quality-of-life end points in cancer clinical trials: The U.S. Food and drug administration perspective. Journal of the National Cancer Institute. Monographs, 20, 7\u20139.","journal-title":"Journal of the National Cancer Institute. Monographs"},{"key":"9365_CR7","first-page":"1155","volume":"69","author":"J. R. Johnson","year":"1985","unstructured":"Johnson, J. R., & Temple, R. (1985). Food and drug administration requirements for approval of new anticancer drugs. Cancer Treatment Reports, 69, 1155\u20131159.","journal-title":"Cancer Treatment Reports"},{"key":"9365_CR8","doi-asserted-by":"crossref","unstructured":"Lipscomb, J., Donaldson, M. S., Arora, N. K., et\u00a0al. (2004). Cancer outcomes research. Journal of the National Cancer Institute. Monographs, 33, 178\u2013197. doi: 10.1093\/jncimonographs\/lgh039.","DOI":"10.1093\/jncimonographs\/lgh039"},{"key":"9365_CR9","doi-asserted-by":"crossref","unstructured":"Dancey, J., Zee, B., Osoba, D., et\u00a0al. (1997). Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical trials Group. Quality of Life Research, 6, 151\u2013158. doi: 10.1023\/A:1026442201191.","DOI":"10.1023\/A:1026442201191"},{"key":"9365_CR10","unstructured":"Okuda, K., Ohtsuki, T., Obata, H., et\u00a0al. (1985). Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer, 56, 918\u2013928. 10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E."},{"key":"9365_CR11","doi-asserted-by":"crossref","unstructured":"The Cancer of Liver Italian Program Investigators. (1998). A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology (Baltimore, Md.), 28, 751\u2013755. doi: 10.1002\/hep.510280322.","DOI":"10.1002\/hep.510280322"},{"key":"9365_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"J. M. Llovet","year":"1999","unstructured":"Llovet, J. M., Bru, C., & Bruix, J. (1999). Prognosis of hepatocellular carcinoma: The BCLC staging classification. Seminars in Liver Disease, 19, 329\u2013338.","journal-title":"Seminars in Liver Disease"},{"key":"9365_CR13","doi-asserted-by":"crossref","unstructured":"Chevret, S., Trinchet, J. C., Mathieu, D., et\u00a0al. (1999). A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d\u2019Etude et de Traitement du Carcinome Hepatocellulaire. Journal of Hepatology, 31, 133\u2013141. doi: 10.1016\/S0168-8278(99)80173-1.","DOI":"10.1016\/S0168-8278(99)80173-1"},{"key":"9365_CR14","doi-asserted-by":"crossref","unstructured":"Ueno, S., Tanabe, G., Sako, K., et\u00a0al. (2001). Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of Liver Italian Program. Hepatology (Baltimore, Md.), 34, 529\u2013534. doi: 10.1053\/jhep.2001.27219.","DOI":"10.1053\/jhep.2001.27219"},{"key":"9365_CR15","doi-asserted-by":"crossref","unstructured":"Dilou, N., Patouillard, B., & Audigier, J. C. (2004). Les classifications de pr\u00e9diction de survie du carcinome h\u00e9patocellulaire. Gastroenterologie Clinique et Biologique, 28, 359\u2013366. doi: 10.1016\/S0399-8320(04)94936-6.","DOI":"10.1016\/S0399-8320(04)94936-6"},{"key":"9365_CR16","doi-asserted-by":"crossref","unstructured":"The Cancer of Liver Italian Program Investigators. (2000). Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology (Baltimore, Md.), 31, 840\u2013845. doi: 10.1053\/he.2000.5628.","DOI":"10.1053\/he.2000.5628"},{"key":"9365_CR17","doi-asserted-by":"crossref","unstructured":"Levy, I., Sherman, M., & The Liver Cancer Study Group of the University of Toronto (2002). Staging of hepatocellular carcinoma: Assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut, 50, 881\u2013885. doi: 10.1136\/gut.50.6.881.","DOI":"10.1136\/gut.50.6.881"},{"key":"9365_CR18","doi-asserted-by":"crossref","unstructured":"Wildi, S., Pestalozzi, B. C., McCormack, L., & Clavien, P. A. (2004). Critical evaluation of the different staging systems for hepatocellular carcinoma. British Journal of Surgery, 91, 400\u2013408. doi: 10.1002\/bjs.4554.","DOI":"10.1002\/bjs.4554"},{"key":"9365_CR19","doi-asserted-by":"crossref","unstructured":"Farinati, F., Rinaldi, M., Gianni, S., & Naccarato, R. (2000). How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer, 89, 2266\u20132273. doi :10.1002\/1097-0142(20001201)89:11<2266::AID-CNCR15>3.0.CO;2-0.","DOI":"10.1002\/1097-0142(20001201)89:11<2266::AID-CNCR15>3.0.CO;2-0"},{"key":"9365_CR20","doi-asserted-by":"crossref","unstructured":"Marrero, J. A., Fontana, R. J., Barrat, A., et\u00a0al. (2005). Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort. Hepatology (Baltimore, Md.), 41, 707\u2013716. doi: 10.1002\/hep.20636.","DOI":"10.1002\/hep.20636"},{"key":"9365_CR21","doi-asserted-by":"crossref","unstructured":"Leung, T. W., Tang, A. M., Zee, B., et\u00a0al. (2002). Construction of the Chinese university prognostic index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the liver Italian program staging system: A study based on 926 patients. Cancer, 94, 1760\u20131769. doi: 10.1002\/cncr.10384.","DOI":"10.1002\/cncr.10384"},{"key":"9365_CR22","doi-asserted-by":"crossref","unstructured":"Cillo, U., Vitale, A., Grigoletto, F., et\u00a0al. (2006). Prospective validation of the Barcelona clinic liver cancer staging system. Journal of Hepatology, 44, 723\u2013731. doi: 10.1016\/j.jhep.2005.12.015.","DOI":"10.1016\/j.jhep.2005.12.015"},{"key":"9365_CR23","doi-asserted-by":"crossref","unstructured":"Barbare, J. C., Bouch\u00e9, O., Bonnetain, F., et\u00a0al. (2005). Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma. Journal of Clinical Oncology, 23, 4338\u20134346. doi: 10.1200\/JCO.2005.05.470.","DOI":"10.1200\/JCO.2005.05.470"},{"key":"9365_CR24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejca.2008.01.004","volume":"44","author":"M. Doffo\u00ebl","year":"2008","unstructured":"Doffo\u00ebl, M., Bonnetain, F., Bouch\u00e9, O., et\u00a0al. (2008). Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive 9402). European Journal of Cancer, 44, 528\u2013538.","journal-title":"European Journal of Cancer"},{"key":"9365_CR25","doi-asserted-by":"crossref","unstructured":"Spitzer, W. O., Dobson, A. J., Hall, J., et\u00a0al. (1981). Measuring the quality of life of cancer patients. A concise QL-Index for use by physician. Journal of Chronic Diseases, 34, 585\u2013597. doi: 10.1016\/0021-9681(81)90058-8.","DOI":"10.1016\/0021-9681(81)90058-8"},{"key":"9365_CR26","doi-asserted-by":"crossref","unstructured":"Anderson, R. T., Aaronson, N. K., & Wilkin, D. (1993). Critical review of the international assessments of heath-related quality of life. Quality of Life Research, 2, 369\u2013395. doi: 10.1007\/BF00422215.","DOI":"10.1007\/BF00422215"},{"key":"9365_CR27","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1200\/JCO.1998.16.11.3662","volume":"16","author":"J. A. Sloan","year":"1998","unstructured":"Sloan, J. A., Loprinzi, C. L., Kuross, S. A., et\u00a0al. (1998). Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. Journal of Clinical Oncology, 16, 3662\u20133673.","journal-title":"Journal of Clinical Oncology"},{"key":"9365_CR28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V. Mazzaferro","year":"1996","unstructured":"Mazzaferro, V., Regalia, E., Doci, R., et\u00a0al. (1996). Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England Journal of Medicine, 334, 693\u2013699.","journal-title":"New England Journal of Medicine"},{"key":"9365_CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"F. E. Harrell","year":"1996","unstructured":"Harrell, F. E., Lee, K. L., & Mark, D. B. (1996). Tutorial in biostatistics. Multivariable prognostic models issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine, 15, 361\u2013387.","journal-title":"Statistics in Medicine"},{"key":"9365_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00435257","volume":"3","author":"G. I. Ringdal","year":"1994","unstructured":"Ringdal, G. I., Ringdal, K., Kvinnsland, S., et\u00a0al. (1994). Quality of life of cancer patients with different prognosis. Quality of Life Research, 3, 143\u2013154.","journal-title":"Quality of Life Research"},{"key":"9365_CR31","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/bjc.1996.300","volume":"73","author":"G. I. Ringdal","year":"1996","unstructured":"Ringdal, G. I., Gotestam, K. G., Kaasa, S., et\u00a0al. (1996). Prognostic factors and survival in a heterogeneous sample of cancer patients. British Journal of Cancer, 73, 1594\u20131599.","journal-title":"British Journal of Cancer"},{"key":"9365_CR32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0959-8049(97)00049-X","volume":"33","author":"A. Coates","year":"1997","unstructured":"Coates, A., Porzsolt, F., & Osoba, D. (1997). Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. European Journal of Cancer, 33, 1025\u20131030.","journal-title":"European Journal of Cancer"},{"key":"9365_CR33","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1200\/JCO.1993.11.10.2050","volume":"11","author":"A. Coates","year":"1993","unstructured":"Coates, A., Forbes, J., & Simes, R. J. (1993). Prognostic value of performance status and quality of life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group. Journal of Clinical Oncology, 11, 2050\u20132051.","journal-title":"Journal of Clinical Oncology"},{"key":"9365_CR34","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0959-8049(00)00144-1","volume":"36","author":"J. A. Kramer","year":"2000","unstructured":"Kramer, J. A., Curran, D., Piccart, M., et\u00a0al. (2000). Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. European Journal of Cancer, 36, 1498\u20131506.","journal-title":"European Journal of Cancer"},{"key":"9365_CR35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ejca.2004.01.014","volume":"40","author":"F. Efficace","year":"2004","unstructured":"Efficace, F., Biganzoli, L., Piccart, M., et\u00a0al. (2004). Baseline health-related quality of life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. European Journal of Cancer, 40, 1021\u20131030.","journal-title":"European Journal of Cancer"},{"key":"9365_CR36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-8140(00)00158-4","volume":"55","author":"H. Langendijk","year":"2000","unstructured":"Langendijk, H., Aaronson, N. K., de Jong, J. M. A., et\u00a0al. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy and Oncology, 55, 19\u201325.","journal-title":"Radiotherapy and Oncology"},{"key":"9365_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0169-5002(00)00179-3","volume":"31","author":"A. Montazeri","year":"2001","unstructured":"Montazeri, A., Milroy, R., Hole, D., et\u00a0al. (2001). Quality of life in lung cancer patients as an important prognostic factor. Lung Cancer, 31, 233\u2013240.","journal-title":"Lung Cancer"},{"key":"9365_CR38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<333::AID-CNCR10>3.0.CO;2-Q","volume":"85","author":"J. E. Herndon","year":"1999","unstructured":"Herndon, J. E., Fleishman, S., Kornblith, A. N., et\u00a0al. (1999). Is quality of life predictive of the survival of patients with advanced non small cell lung carcinoma? Cancer, 85, 333\u2013340.","journal-title":"Cancer"},{"key":"9365_CR39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1023\/B:QURE.0000037481.36604.eb","volume":"13","author":"M. Dharma Wardene","year":"2004","unstructured":"Dharma-Wardene, M., Au, H. J., Hanson, J., et\u00a0al. (2004). Baseline FACT-G score is a predictor of survival for advanced lung cancer. Quality of Life Reseach, 13, 1209\u20131216.","journal-title":"Quality of Life Reseach"},{"key":"9365_CR40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/gut.49.2.227","volume":"49","author":"J. M. Blazeby","year":"2001","unstructured":"Blazeby, J. M., Brookes, S. T., & Alderson, D. (2001). The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut, 49, 227\u2013230.","journal-title":"Gut"},{"key":"9365_CR41","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2003.09.100","volume":"58","author":"F. M. Fang","year":"2004","unstructured":"Fang, F. M., Tsai, W. L., Chiu, H., et\u00a0al. (2004). Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. International Journal of Radiation, Biology, Physics, 58, 1394\u20131404.","journal-title":"nternational Journal of Radiation, Biology, Physics"},{"key":"9365_CR42","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2004.08.154","volume":"22","author":"I. Chau","year":"2004","unstructured":"Chau, I., Norman, A. R., Cunningham, D., et\u00a0al. (2004). Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trails using individual patients data. Journal of Clinical Oncology, 22, 2395\u20132403.","journal-title":"Journal of Clinical Oncology"},{"key":"9365_CR43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0959-8049(00)00385-3","volume":"37","author":"A. de Graeff","year":"2001","unstructured":"de Graeff, A., de Leeuw, J. R. J., Ros, W. J. G., et\u00a0al. (2001). Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. European Journal of Cancer, 37, 332\u2013339.","journal-title":"European Journal of Cancer"},{"key":"9365_CR44","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.0.CO;2-M","volume":"39","author":"S. D. Ramsey","year":"2000","unstructured":"Ramsey, S. D., Anderson, M. R., Etzioni, R., et\u00a0al. (2000). Quality of life in survivors of colorectal carcinoma. Cancer, 39, 1294\u20131303.","journal-title":"Cancer"},{"key":"9365_CR45","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/0959-8049(93)90115-V","volume":"29","author":"A. Coates","year":"1993","unstructured":"Coates, A., Thomson, D., McLeod, G. R., et\u00a0al. (1993). Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. European Journal of Cancer, 29A, 1731\u20131734.","journal-title":"European Journal of Cancer"},{"key":"9365_CR46","doi-asserted-by":"crossref","unstructured":"Wisloff, F., Hjorth, M., et\u00a0al., for the Nordic Myeloma Study Group. (1997). Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. British Journal of Haematology, 97, 29\u201337.","DOI":"10.1046\/j.1365-2141.1997.222667.x"},{"key":"9365_CR47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/gyno.1995.0014","volume":"59","author":"A. B. Kornblith","year":"1995","unstructured":"Kornblith, A. B., Thaler, H. T., Wong, G., et\u00a0al. (1995). Quality of life of women with ovarian cancer. Gynecologic oncology, 59, 231\u2013242.","journal-title":"Gynecologic Oncology"},{"key":"9365_CR48","first-page":"921","volume":"26","author":"H. Langendijk","year":"1999","unstructured":"Langendijk, H., Aaronson, N. K., ten Velde, G. P., et\u00a0al. (1999). Pretreatment quality of life in patients with gIioblastoma multiforme. Oncology Nursing Forum, 26, 921\u2013925.","journal-title":"Oncology Nursing Forum"},{"key":"9365_CR49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/annonc\/mdl065","volume":"17","author":"W. Yeo","year":"2006","unstructured":"Yeo, W., Mo, F. K., Koh, J., et\u00a0al. (2006). Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Annals of Oncology, 17, 1083\u20131089.","journal-title":"Annals of Oncology"},{"key":"9365_CR50","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","volume":"19","author":"D. Altman","year":"2000","unstructured":"Altman, D., & Royston, P. (2000). What do we mean by validating a prognostic model? Statistics in Medicine, 19, 453\u2013473.","journal-title":"Statistics in Medicine"},{"key":"9365_CR51","doi-asserted-by":"crossref","unstructured":"Barbare, J. C., Bouch\u00e9, O., Bonnetain, F., et\u00a0al. (2005). Treatment of advanced hepatocellular carcinoma with long-acting octreotide: Preliminary results of a randomized placebo-controlled trial (FFCD-ANGH 2001\u201301 CHOC). Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings, 23(16S), 4036.","DOI":"10.1200\/jco.2005.23.16_suppl.4036"},{"key":"9365_CR52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.1994.03520080061045","volume":"272","author":"T. M. Gill","year":"1994","unstructured":"Gill, T. M., & Feinstein, A. R. (1994). A critical appraisal of the quality of quality-of-life measurements. The Journal of the American Medical Association, 272, 619\u2013626.","journal-title":"The Journal of the American Medical Association"},{"key":"9365_CR53","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1200\/JCO.2007.12.4644","volume":"25","author":"J. Lipscomb","year":"2007","unstructured":"Lipscomb, J., Reeve, B. B., Clauser, S. B., et\u00a0al. (2007). Patient-reported outcomes assessment in cancer trials: Taking stock, moving forward. Journal of Clinical Oncology, 25, 5133\u20135140.","journal-title":"Journal of Clinical Oncology"},{"key":"9365_CR54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<725::AID-SIM817>3.0.CO;2-1","volume":"17","author":"R. J. Simes","year":"1998","unstructured":"Simes, R. J., Greatorex, V., & Gebski, V. J. (1998). Practical approaches to minimize problems with missing quality of life data. Statistics in Medicine, 17, 725\u2013737.","journal-title":"Statistics in Medicine"},{"key":"9365_CR55","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<517::AID-SIM799>3.0.CO;2-S","volume":"17","author":"J. Bernhard","year":"1998","unstructured":"Bernhard, J., Cella, D. F., Coates, A. S., et\u00a0al. (1998). Missing quality of life data in cancer clinical trials : Serious problems and challenges. Statistics in Medicine, 17, 517\u2013532.","journal-title":"Statistics in Medicine"},{"key":"9365_CR56","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1054\/bjoc.2001.1785","volume":"84","author":"J. Bernhard","year":"2001","unstructured":"Bernhard, J., Sullivan, M., Hurny, C., et\u00a0al. (2001). Clinical relevance of single item quality of life indicators in cancer clinical trials. British Journal of Cancer, 84, 1156\u20131165.","journal-title":"British Journal of Cancer"},{"key":"9365_CR57","doi-asserted-by":"crossref","unstructured":"Sloan, J. A., Aaronson, N., Cappelleri, J. C., et\u00a0al., Clinical Significance Consensus Meeting Group. (2002). Assessing the clinical significance of single items relative to summated scores. Mayo Clinic Proceedings, 77, 479\u2013487.","DOI":"10.1016\/S0025-6196(11)62218-0"},{"key":"9365_CR58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0399-8320(07)89370-5","volume":"1","author":"J. L. Caumes","year":"2007","unstructured":"Caumes, J. L., Nousbaum, J. B., Bessaguet, C., et\u00a0al. (2007). Epidemiology of hepatocellular carcinoma in Finist\u00e8re. Prospective study from June 2002 to May 2003. Gastroenterologie Clinique et Biologique, 1, 259\u2013264.","journal-title":"Gastroenterologie Clinique et Biologique"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-008-9365-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-008-9365-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-008-9365-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:52:41Z","timestamp":1559375561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-008-9365-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,10]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9365"],"URL":"https:\/\/doi.org\/10.1007\/s11136-008-9365-y","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,10]]}}}